BIOBV Biohit Oyj
2.390EUR+1.27%Mkt Cap: 39.50M $P/E: 11.951d ago
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The compan…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap39.50M USD
Enterprise Value37.38M USD
Revenue (TTM)17.53M USD
Gross Profit11.68M USD
Net Income (TTM)2.98M USD
Revenue/Share1.06 EUR
Last Price2.390 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees47
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI0009005482
Valuation
P/E (Trailing)11.95
P/E (Forward)13.88
PEG7.04
EV/EBITDA10.02
EV/Revenue2.13
P/S2.22
P/B2.22
EPS (TTM)0.20
EPS (Forward)0.17
52W Range
2.20012% of range3.780
52W High3.780 EUR
52W Low2.200 EUR
Profitability
Gross Margin68.33%
Oper. Margin19.23%
EBITDA Margin21.28%
Profit Margin17.40%
ROE18.33%
ROA13.82%
Growth
Revenue Growth5.40%
Earnings Growth35.00%
Cash Flow & Leverage
Operating CF-813.04K USD
CapEx (TTM)668.48K USD
FCF Margin8.75%
FCF Yield3.88%
Net Debt-1.63M USD
Net Debt/EBITDA-0.44
Balance Sheet
Debt/Equity0.11
Current Ratio2.31
Quick Ratio2.06
Book Value/Sh1.06 EUR
Cash/Share0.19 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 15, 2014
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.300 EUR
Upside (mean)+38.1%
Target Range3.300 EUR – 3.300 EUR
# Analysts1
Ownership
Shares Out.12.23M
Float7.17M
Insiders49.08%
Institutions0.00%
Technical
SMA 502.550 (-6.3%)
SMA 2002.697 (-11.4%)
Beta0.56
S&P 52W Chg16.45%
Avg Vol (30d)6.52K
Avg Vol (10d)4.42K
Technical Indicators
RSI (14)46.8
MACD-0.0371
MACD Signal-0.0488
MACD Hist.+0.0117
BB Upper2.527 EUR
BB Middle2.403 EUR
BB Lower2.279 EUR
BB Width10.32%
ATR (14)0.1077 EUR
Vol Ratio (20d)0.58x